Quarterly Surge: Premier Health Unveils Robust Financial Performance for 2025
Premier Health of America Reports Q1 2025 Financial Results
MONTRÉAL, February 28, 2025 - Premier Health of America Inc. (TSXV: PHA), a pioneering Canadian Healthtech company, has released its unaudited Quarterly Consolidated Financial Statements and Management's Discussion and Analysis for the first quarter ending December 31st, 2024.
Financial Highlights
Financial Metric | Q1 2025 (3 months) | Q1 2024 (3 months) |
---|---|---|
Revenues | $32,132,000 | $36,973,000 |
Gross Margin | $5,137,000 | $7,657,000 |
Gross Margin Percentage | 16.0% | 20.1% |
Adjusted EBITDA | $705,000 | $2,622,000 |
The company continues to navigate a dynamic market environment while maintaining its commitment to innovation and strategic growth.